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Adenocarcinoma is the second most common malignant tumor of the small 
bowel after carcinoid tumor. It usually located in the duodenal region with an 
average age of diagnosis of 67. Seven percent of cases present with overt 
gastrointestinal bleeding. Primary small bowel malignancy is rare, accounting 
for 3% of gastrointestinal tract neoplasms and 0.5% of all cancers in the United 
States.  Metastatic lesions to the small bowel are even more rare. They can be 
seen in the setting of peritoneal carcinomatosis with local extension. Melanoma, 
sarcoma, lung, breast, cervical and colonic tumors are more likely to spread 
to the small bowel hematogenously. Distant metastases from head and neck 
cancers can be found in 7.4% of patients using PET/CT, and most commonly 
involve the lungs, liver and bone.  Gastroenterologists need to be considerate of 
small bowel neoplasms in patients with OGIB.Obscure gastrointestinal bleed (OGIB) 
is defined as occult or overt bleeding 
of unknown origin that persists after 
initial negative endoscopic evaluation. 
After considering repeat endoscopies 
other assessment options include 
push enteroscopy (PE), video capsule 
endoscopy (VCE) and double-balloon 
enteroscopy (DBE). We describe two 
patients who presented with OGIB 
related to malignancy.
A 60-year-old male with a prior history of localized tonsillar SCC 
treated with chemoradiation was deemed to have NED three years 
ago.  He presented with six weeks of fatigue and melena.  Initial 
laboratory evaluation confirmed iron deficiency anemia. A 
screening colonoscopy one month prior was normal.  Inpatient 
EGD was unremarkable.  VCE revealed bleeding in the jejunum.  PE 
showed blood refluxing into the most distal reachable site.  DBE 
revealed a circumferential luminal mass with denuded, ulcerated 
mucosa.  Biopsy showed moderately differentiated SCC.  Abdominal 
CT showed diffuse adenopathy with a focal area of small bowel 
thickening.  Further evaluation and treatment are pending.
Figure 1. Hemi-circumferential ulcerated mass found to be 
adenocarcinoma of the small bowel on biopsy.
Case 1
A 43-year-old male presented with worsening fatigue and was 
found to have profound anemia requiring blood transfusion.  No 
source of GIB was found on routine upper endoscopy and 
colonoscopy.   VCE findings suggested a relatively proximal 
bleeding duodenal mass.  A PE showed a duodenal AVM as well as 
a hemi-circumferential ulcerated mass in the third portion of the 
duodenum.  Pathology was consistent with adenocarcinoma. Follow 
up abdominal and thoracic CT showed multifocal adenopathy with 
a mass in the distal duodenum. LN biopsy confirmed metastatic 
duodenal adenocarcinoma.  Given his disease stage he was not felt 
to be a surgical candidate.  He was started on FOLFOX therapy in an 
attempt to downstage his disease.
DiscussionCase 2
Figure 2. Circumferential jejunal mass found to be metastatic 
squamous cell carcinoma on biopsy.
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Table 1. Common Causes of Obscure Gastrointestinal Bleeding
Over Age 50 Under Age 50
(Angioectasias (30-40%) Tumors (carcinoid, leiomyoma, lymphoma, adenocarcinoma)
NSAID Enteropathy
Inflammatory Bowel Disease
Meckel’s Diverticulum
Dieulafoy’s Lesions
Background
